Capping Off The Rebate Debate: Will 2019 Price Push End With Co-Pay Cap?

The pharmaceutical industry and its strongest critics have long agreed on one thing: Medicare Part D would be improved if there was a cap on spending by beneficiaries. Now, there is an unlikely path that may make it surprisingly easy to get it done.

Smooth Focus,There is no money left in the bag, only the credit card that is used to the full limit and cannot be used to buy the necessary items because of wrong money management
Seniors might find more money in their wallets if Congress can agree to a co-pay cap for Part D.

More from Pricing Debate

More from Market Access